Menu
GeneBe

PDE6H

phosphodiesterase 6H, the group of Phosphodiesterases

Basic information

Region (hg38): 12:14973041-14981865

Links

ENSG00000139053NCBI:5149OMIM:601190HGNC:8790Uniprot:Q13956AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • retinal cone dystrophy 3A (Strong), mode of inheritance: AR
  • retinal cone dystrophy 3A (Strong), mode of inheritance: AR
  • achromatopsia (Supportive), mode of inheritance: AR
  • retinal cone dystrophy 3A (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Achromatopsia 6; Retinal cone dystrophy 3AAD/ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingOphthalmologic15629837; 22901948
Inheritance is unclear, and may involve recessive model or incomplete penetrance

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PDE6H gene.

  • not provided (50 variants)
  • Retinal cone dystrophy 3A (17 variants)
  • Inborn genetic diseases (2 variants)
  • PDE6H-Related Disorders (1 variants)
  • Achromatopsia 6 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDE6H gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
9
clinvar
1
clinvar
10
missense
26
clinvar
26
nonsense
1
clinvar
1
start loss
1
clinvar
1
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
2
4
6
non coding
7
clinvar
5
clinvar
4
clinvar
16
Total 0 0 35 14 5

Variants in PDE6H

This is a list of pathogenic ClinVar variants found in the PDE6H region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-14973055-C-A Retinal cone dystrophy 3A Benign (Jan 13, 2018)883444
12-14973069-G-C Retinal cone dystrophy 3A Benign (Jan 13, 2018)307780
12-14973086-C-T Retinal cone dystrophy 3A Uncertain significance (Apr 27, 2017)883445
12-14977984-G-C Retinal cone dystrophy 3A Benign/Likely benign (Oct 01, 2022)307781
12-14978015-G-C Uncertain significance (May 03, 2022)2132603
12-14978021-C-G Uncertain significance (Mar 22, 2022)1914873
12-14978044-C-T Uncertain significance (Sep 26, 2023)1717469
12-14978047-C-G Achromatopsia 6 • Retinal cone dystrophy 3A • PDE6H-related disorder Conflicting classifications of pathogenicity (Jan 12, 2024)37245
12-14978055-G-T Uncertain significance (Nov 28, 2022)1037849
12-14978058-C-T Uncertain significance (Oct 05, 2022)2078803
12-14978065-C-T not specified Uncertain significance (Sep 26, 2022)2313402
12-14978070-C-T Uncertain significance (Jul 26, 2022)1011369
12-14978071-G-A Retinal cone dystrophy 3A Uncertain significance (Jan 19, 2024)883446
12-14978071-G-T Uncertain significance (Mar 20, 2021)1348429
12-14978073-A-G Uncertain significance (Oct 30, 2023)1044479
12-14978084-C-G Likely benign (Feb 08, 2023)763984
12-14978102-G-A Likely benign (Jun 25, 2023)2790999
12-14978107-G-A Uncertain significance (Sep 12, 2022)1350820
12-14978111-A-G Likely benign (Nov 26, 2019)1118089
12-14978124-C-A Uncertain significance (Oct 24, 2022)2015800
12-14978128-C-G Uncertain significance (Mar 20, 2022)2109994
12-14978129-A-G Likely benign (Apr 20, 2023)1150936
12-14978136-G-A Uncertain significance (Aug 05, 2022)1953021
12-14978137-G-A Uncertain significance (Jan 13, 2021)1355392
12-14978140-T-A Uncertain significance (Sep 26, 2021)1505184

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PDE6Hprotein_codingprotein_codingENST00000266395 38844
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.008290.5811256870251257120.0000994
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.1954346.70.9200.00000241542
Missense in Polyphen2223.890.92087273
Synonymous-0.7321915.31.247.28e-7159
Loss of Function0.20833.420.8781.44e-744

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00006150.0000615
Ashkenazi Jewish0.00009930.0000992
East Asian0.000.00
Finnish0.00004620.0000462
European (Non-Finnish)0.0001320.000132
Middle Eastern0.000.00
South Asian0.0001310.000131
Other0.0004900.000489

dbNSFP

Source: dbNSFP

Function
FUNCTION: Participates in processes of transmission and amplification of the visual signal. cGMP-PDEs are the effector molecules in G-protein-mediated phototransduction in vertebrate rods and cones.;
Disease
DISEASE: Cone dystrophy, retinal 3A (RCD3A) [MIM:610024]: A rare form of cone dystrophy associated with supernormal rod responses. The disorder is characterized by reduced visual acuity, photoaversion, night blindness, and abnormal color vision. At an early age, the retina shows subtle depigmentation at the macula and, later, more obvious areas of atrophy. {ECO:0000269|PubMed:15629837}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Purine metabolism - Homo sapiens (human);Phosphodiesterases in neuronal function;Purine nucleotides nucleosides metabolism;Visual signal transduction: Cones (Consensus)

Recessive Scores

pRec
0.129

Intolerance Scores

loftool
0.539
rvis_EVS
0.1
rvis_percentile_EVS
60.96

Haploinsufficiency Scores

pHI
0.327
hipred
N
hipred_score
0.398
ghis
0.463

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.583

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pde6h
Phenotype

Gene ontology

Biological process
activation of MAPK activity;visual perception;negative regulation of catalytic activity;positive regulation of epidermal growth factor receptor signaling pathway;positive regulation of G protein-coupled receptor signaling pathway;response to stimulus
Cellular component
Molecular function
enzyme inhibitor activity;protein binding;cGMP binding;3',5'-cyclic-GMP phosphodiesterase activity